Estimates Revisions PharmaEssentia Corporation
Stocks
6446
TW0006446008
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,155.00 TWD | -3.35% |
|
+8.96% | +145.74% |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 06-11 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 6446 Stock
- Consensus PharmaEssentia Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
